These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28679969)

  • 1. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
    Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
    Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouse.
    Kato C; Fujii E; Chen YJ; Endaya BB; Matsubara K; Suzuki M; Ohnishi Y; Tamaoki N
    Lab Anim; 2009 Oct; 43(4):402-4. PubMed ID: 19505936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
    Katano I; Ito R; Eto T; Aiso S; Ito M
    Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
    J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
    Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
    PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of human Graafian follicles following transplantation of human ovarian tissue into NOD/SCID/gammac null mice.
    Terada Y; Terunuma-Sato Y; Kakoi-Yoshimoto T; Hasegawa H; Ugajin T; Koyanagi Y; Ito M; Murakami T; Sasano H; Yaegashi N; Okamura K
    Am J Reprod Immunol; 2008 Dec; 60(6):534-40. PubMed ID: 19032615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
    Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
    Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
    Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
    Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg
    Nagatani M; Kodera T; Suzuki D; Igura S; Fukunaga Y; Kanemitsu H; Nakamura D; Mochizuki M; Kemi M; Tamura K; Kasahara K
    Exp Anim; 2019 Nov; 68(4):471-482. PubMed ID: 31118345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
    Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
    J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
    Ito M; Kobayashi K; Nakahata T
    Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
    Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
    Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
    Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
    Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background data on NOD/Shi-scid IL-2Rγ
    Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
    J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice.
    Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y
    Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.